These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9540134)

  • 1. Betablockers: old concept in a modern approach.
    Hansson BG
    Scand Cardiovasc J Suppl; 1998; 47():57-9. PubMed ID: 9540134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
    Ruffolo RR; Feuerstein GZ
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of carvedilol controlled-release in cardiovascular disease.
    Fonarow GC
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):483-98. PubMed ID: 19419256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.
    Dunn CJ; Lea AP; Wagstaff AJ
    Drugs; 1997 Jul; 54(1):161-85. PubMed ID: 9211087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Are all beta-adrenoblockers equally effective? Place of carvedilol in the treatment of cardiovascular diseases].
    Tereshchenko SN; Zhirov IV
    Ter Arkh; 2007; 79(4):86-90. PubMed ID: 17564027
    [No Abstract]   [Full Text] [Related]  

  • 6. Vasodilatory action of carvedilol.
    Sponer G; Strein K; Bartsch W; Müller-Beckmann B
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S5-11. PubMed ID: 1378150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvedilol for heart failure: renewed interest in beta blockers.
    Young JB
    Cleve Clin J Med; 1997 Sep; 64(8):415-22. PubMed ID: 9308217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of carvedilol in experimental viral myocarditis.
    Yue-Chun L; Li-Sha G; Xue-Qiang G; Jia-Feng L
    Curr Pharm Des; 2012; 18(12):1620-4. PubMed ID: 22443630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of carvedilol alone versus carvedilol + pimobendan for severe congestive heart failure. For the Keio Interhospital Cardiology Study (KICS) Group.
    Yoshikawa T; Baba A; Suzuki M; Yokozuka H; Okada Y; Nagami K; Takahashi T; Mitamura H; Ogawa S
    Am J Cardiol; 2000 Jun; 85(12):1495-7; A7. PubMed ID: 10856401
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of salt intake on the antihypertensive effect of carvedilol.
    Ruilope LM; Lahera V
    J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.
    Sanderson JE; Chan SK; Yip G; Yeung LY; Chan KW; Raymond K; Woo KS
    J Am Coll Cardiol; 1999 Nov; 34(5):1522-8. PubMed ID: 10551702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical updates on carvedilol: a first choice beta-blocker in the treatment of cardiovascular diseases.
    Chakraborty S; Shukla D; Mishra B; Singh S
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):237-50. PubMed ID: 20073998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined alpha and beta blockers in the therapy of cardiovascular diseases].
    Tavciovski D; Romanović R; Bosković S; Duran P; Matunović R
    Vojnosanit Pregl; 2002; 59(4):405-10. PubMed ID: 12235748
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of carvedilol on left ventricular function and mass in hypertension.
    Why HJ; Richardson PJ
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S50-4. PubMed ID: 1378151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvedilol in hypertension treatment.
    Stafylas PC; Sarafidis PA
    Vasc Health Risk Manag; 2008; 4(1):23-30. PubMed ID: 18629377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Betablockers in heart failure: Carvedilol Safety Assessment (CASA 2-trial).
    Rickli H; Steiner S; Müller K; Hess OM
    Eur J Heart Fail; 2004 Oct; 6(6):761-8. PubMed ID: 15542414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic profile of carvedilol.
    van Zwieten PA
    Cardiology; 1993; 82 Suppl 3():19-23. PubMed ID: 8106159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study.
    Bhatt P; Makwana D; Santani D; Goyal R
    Can J Physiol Pharmacol; 2007 May; 85(5):514-20. PubMed ID: 17632586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term oral carvedilol in chronic heart failure.
    Di Lenarda A; Sabbadini G; Moretti M; Sinagra G
    Expert Opin Pharmacother; 2004 Jun; 5(6):1359-72. PubMed ID: 15163280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics and pharmacodynamics of carvedilol.
    Morgan T
    Clin Pharmacokinet; 1994 May; 26(5):335-46. PubMed ID: 7914479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.